← Back to Search

Intraocular Lens

Intraocular Lenses for Cataracts

N/A
Waitlist Available
Led By Yaping Jin, MD, PhD
Research Sponsored by University of Toronto
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 18 month follow-up
Awards & highlights

Study Summary

This trial will test the rate of glistenings in patients with new generations of intraocular lenses from two manufacturers.

Eligible Conditions
  • Cataract
  • Transient Visual Acuity Loss
  • Loss of Visual Contrast Sensitivity
  • Functional Visual Loss

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~18-month follow-up
This trial's timeline: 3 weeks for screening, Varies for treatment, and 18-month follow-up for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Incidence and density (severity) of glistenings at 18-month follow-up visit
Secondary outcome measures
Contrast sensitivity and glare disability in eyes with glistenings at 12-month follow-up visit
Contrast sensitivity in eyes with glistenings at 18-month follow-up visit
Contrast sensitivity in eyes with glistenings at 6-month follow-up visit
+8 more

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Alcon lens groupExperimental Treatment1 Intervention
Alcon 1 piece SA60AT lens
Group II: AMO lens groupActive Control1 Intervention
AMO 1 piece Sensar AABOO lens

Find a Location

Who is running the clinical trial?

University of TorontoLead Sponsor
689 Previous Clinical Trials
1,018,621 Total Patients Enrolled
2 Trials studying Cataract
630 Patients Enrolled for Cataract
Kensington Eye InstituteOTHER
2 Previous Clinical Trials
445 Total Patients Enrolled
Yaping Jin, MD, PhDPrincipal InvestigatorUniversity of Toronto

Media Library

Alcon 1 piece SA60AT lens (Intraocular Lens) Clinical Trial Eligibility Overview. Trial Name: NCT03409185 — N/A
Alcon 1 piece SA60AT lens (Intraocular Lens) 2023 Treatment Timeline for Medical Study. Trial Name: NCT03409185 — N/A
Cataract Research Study Groups: Alcon lens group, AMO lens group
Cataract Clinical Trial 2023: Alcon 1 piece SA60AT lens Highlights & Side Effects. Trial Name: NCT03409185 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is there still room for individuals to enroll in this research?

"This research initiative, which was initially posted in July 2017 and updated on the 16th of May 2022, is not presently accepting participants. However, 125 alternative trials are actively seeking enrolments at this moment."

Answered by AI
Recent research and studies
clinicaltrials.govStudy
The Incidence of Glistenings in the 2017 Intraocular Lenses Made by Alcon and Abbott Medical Optics
Yaping Jin 2017. "The Incidence of Glistenings in the 2017 Intraocular Lenses Made by Alcon and Abbott Medical Optics". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT03409185.
~3 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top